ID: 136 No Evidence for an Association of the Tissue-type Plasminogen Activator -7351C/T Enhancer Polymorphism and the Presence of Stable Coronary Artery Disease or the Occurrence of Acute Myocardial Infarction

Walter S. Speidl(University of Applied Sciences St Pölten), Johann Wojta(Medical University of Vienna), O. Wagner, Georg Endler(Medical University of Vienna), Christine Mannhalter(Medical University of Vienna), Kurt Huber(Sigmund Freud Privatuniversität Wien), Christoph Kaun(University of Vienna), Gerlinde Zorn(Wilhelminen Hospital)
Journal of Thrombosis and Haemostasis
October 1, 2006
10.1111/j.1538-7836.2006.00136.x
Cited by 0

Related Papers

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755
Polar secretion of endothelin-1 by cultured endothelial cells.
|Journal of Biological Chemistry|1992|645